The potential clinical impact of quantum dots

Nanomedicine

Volumn 7, Issue 5, 2012, Pages 623-626

  Santra, Swadeshmukul ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

bioimaging; drug delivery; fluorescence; nanomedicine; quantum dot

Indexed keywords

ARSENIC; CADMIUM; CONTRAST MEDIUM; FLUORESCENT DYE; LEAD; NANOCRYSTAL; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; TRIOCTYLPHOSPHINE OXIDE;

BIOCOMPATIBILITY; CANCER CELL; CANCER STAGING; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; INFRARED RADIATION; NANOTECHNOLOGY; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; SOLID TUMOR; SYNTHESIS; TUMOR CELL;

DIAGNOSTIC IMAGING; HUMANS; NANOTECHNOLOGY; ORGANOPHOSPHORUS COMPOUNDS; QUANTUM DOTS;

EID: 84861647296     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.45     Document Type: Review

References (17)

1. Wang YQ, Chen LX. Quantum dots, lighting up the research and development of nanomedicine. Nanomedicine 7(4), 385-402 (2011).
2. Cinteza LO. Quantum dots in biomedical applications: advances and challenges. J. Nanophoton. 4, 042503 (2010).
3. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4(6), 435-446 (2005). (Pubitemid 40774047)
4. Jokerst JV, Gambhir SS. Molecular imaging with theranostic nanoparticles. Acc. Chem. Res. 44(10), 1050-1060 (2011).
5. Zhang H, Yee D, Wang C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (Lond). 3(1), 83-91 (2008). (Pubitemid 351611867)
6. Medintz IL, Mattoussi H, Clapp AR. Potential clinical applications of quantum dots. Int. J. Nanomedicine 3 (2), 151-167 (2008). (Pubitemid 352037849)
7. Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine 3(1), 20-31 (2007). (Pubitemid 46428187)
8. Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin. Chem. 53(11), 2002-2009 (2007). (Pubitemid 350036056)
9. Azzazy HME, Mansour MMH, Kazinierczak SC. From diagnostics to therapy: prospects of quantum dots. Clin. Biochem. 40(13-14), 917-927 (2007).
10. Mitra RN, Doshi M, Zhang XL et al. An activatable multimodal/ multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials 33(5), 1500-1508 (2012).
11. Hauck TS, Anderson RE, Fischer HC, Newbigging S, Chan WCW. In vivo quantum-dot toxicity assessment. Small 6(1), 138-144 (2010).
12. Rzigalinski BA, Strobl JS. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol. Appl. Pharmacol. 238(3), 280-288 (2009).
13. Luo GP, Long J, Zhang B et al. Quantum dots in cancer therapy. Expert Opin. Drug Deliv. 9(1), 47-58 (2012).
14. Altinoglu EI, Adair JH. Near infrared imaging with nanoparticles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2(5), 461-477 (2010).
15. Morrow KJ, Bawa R, Wei CM. Recent advances in basic and clinical nanomedicine. Med. Clin. North Am. 91(5), 805-843 (2007). (Pubitemid 47364736)
16. Ghaderi S, Ramesh B, Seifalian AM. Fluorescence nanoparticles 'quantum dots' as drug delivery system and their toxicity: a review. J. Drug Target. 19(7), 475-486 (2011).
17. Bentolila LA, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. J. Nucl. Med. 50(4), 493-496 (2009).